Listed

Prokidney Corp.: Form 10-Q for the period ended Jun 30, 2022

Filed with the SEC on Aug 12, 2022 and accepted by EDGAR at Aug 11, 2022, 19:59 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2022-04-01 to 2022-06-30−$2.6mus-gaap:OperatingIncomeLoss
Operating income6 months2022-01-01 to 2022-06-30−$6.6mus-gaap:OperatingIncomeLoss
Net income3 months2022-04-01 to 2022-06-30−$2.3mus-gaap:NetIncomeLoss
Net income6 months2022-01-01 to 2022-06-30−$6.3mus-gaap:NetIncomeLoss
Operating cash flow6 months2022-01-01 to 2022-06-30−$582.9kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2022-06-30$107.5kus-gaap:Cash
Current assetsAt period end2022-06-30$632.3kus-gaap:AssetsCurrent
Total assetsAt period end2022-06-30$251.0mus-gaap:Assets
Current liabilitiesAt period end2022-06-30$7.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-06-30$15.6mus-gaap:Liabilities
Shareholders' equityAt period end2022-06-30−$15.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-22-218857. Last ingested by Listed: Nov 13, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.